1% with placebo
Nausea represents the most frequently reported adverse reaction, affecting a significant proportion of patients, particularly during the initial weeks of therapy or following dose increases
Although few animal studies reported an improvement in indices of fibrosis or prevention of the initiation of fibrosis [8, 26, 29], most studies do not support a robust effect of GLP-1RAs on hepatic fibrosis (Table 1)
We design the study with the exact same strict rules as a traditional trial, like who gets included, how they are matched, and how we measure success, but we apply these rules to historical medical records, Xiong said
Immune exclusion as a recurrent immune-escape state driving treatment resistance in osteosarcoma: Insights from single-cell, spatial, and multi-omics studies
External review If UHC upholds the denial on appeal, you may have the right to request an independent external review